Dr. Reddy's recibe aprobación provisional de la FDA para genérico contra el VIH
La FDA de EEUU otorgó a Dr. Reddy's el visto bueno provisional para un medicamento genérico destinado a prevenir el VIH.
Related stories
Nasdaq Notifies House of Doge of Delisting After Bid-Price Violation
Nasdaq notified House of Doge it would delist the company’s common stock after its closing bid price was $0.10 or less for ten consecutive trading days. Trading is set to be suspen
M impact | REGULATION | Nov 02, 2026, 09:25 PM UTC
Snap Settles Teenagers’ Lawsuit Over Social Media Addiction
Snap reached a settlement in a lawsuit brought by teenagers over social media addiction.
M impact | REGULATION | Nov 02, 2026, 08:54 PM UTC
U.S. Treasury Expects to Borrow $618 Billion This Quarter
The Treasury expects $618 billion in privately held net marketable borrowing this quarter, $10 billion less than announced in August. It cited a higher-than-assumed starting cash b
L impact | REGULATION | Nov 02, 2026, 08:45 PM UTC
FTC and 20 States Sue Dollar General Over Store Pricing
The Federal Trade Commission and 20 states filed a federal lawsuit alleging deceptive pricing at Dollar General stores.
M impact | REGULATION | Nov 02, 2026, 08:37 PM UTC
South Africa to Support Sectors Hit by US Trade Initiative Suspension
South Africa says it will support sectors affected by the suspension of a US trade initiative.
L impact | REGULATION | Nov 02, 2026, 08:31 PM UTC
US Judge Dismisses Trump Administration's Harvard Probe Case
A US judge dismissed the Trump administration's case related to its probe of Harvard admissions.
M impact | REGULATION | Nov 02, 2026, 08:14 PM UTC